Material Modification to Rights of Security Holders

Business Context and Reporting Period

This Form 8-K Current Report was filed by Ekso Bionics Holdings, Inc. on May 4, 2016. The report details a material modification to the rights of security holders involving a reverse stock split.

Key Financial Metrics

This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes.

Material Changes

  • Reverse Stock Split: Completed a one-for-seven reverse split of common stock.
  • Share Count Reduction: Outstanding shares decreased from approximately 113.3 million to approximately 16.2 million.
  • Authorized Shares: Reduced from 500,000,000 to 71,428,571.
  • Fractional Shares: Any fractional shares resulting from the split were rounded up to the nearest whole share.
  • Trading Status: Stock began trading on a split-adjusted basis on May 5, 2016.

Guidance, Outlook, and Risks

The filing does not provide forward-looking guidance, management commentary on operations, or specific risk factors beyond the structural change. The company issued a press release regarding the split, which is attached as an exhibit but not deemed "filed" for liability purposes under Section 18 of the Exchange Act.

Investor Verification Checklist

  • Verify the adjusted share count of approximately 16.2 million shares in brokerage accounts.
  • Confirm the new authorized share limit of 71,428,571.
  • Check trading activity on May 5, 2016, to ensure the split-adjusted price reflects the one-for-seven ratio.
  • Review the Certificate of Change filed with the Nevada Secretary of State (Exhibit 3.1) for legal confirmation of the Articles of Incorporation amendment.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.